what was the first glp-1 agonist PDB-101: Molecule of Month: Receptor Agonists Emerging Frontiers in GLP-1 Therapeutics:

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

Explore natural alternatives to GLP-1 drugs like Ozempic and Mounjaro

Encourages balanced appetite & cravings*

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients who want a gentler, cosmetic approach